Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.100 GeneticVariation disease BEFREE In the present study no association between polymorphic CYP1A1 and CYP2E1 genotypes and susceptibility to lung cancer was found. 1306126 1992
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1
0.100 GeneticVariation disease BEFREE It appears that interesting functionally linked interindividual differences in the CYP1A1 gene have been found and could be of importance in understanding differences in susceptibility to lung cancer. 1306127 1992
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.100 AlteredExpression disease BEFREE Since P-glycoprotein expression in lung tumors is generally low, these MDR lung cancer cell lines can be used as a model to study alternative mechanisms leading to multidrug resistance in this tumor type. 1309222 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE The p53 gene has been implicated as a tumor suppressor gene involved in the pathogenesis of lung cancer. 1310070 1992
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.100 AlteredExpression disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 5295
Gene Symbol: PIK3R1
PIK3R1
0.020 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 54776
Gene Symbol: PPP1R12C
PPP1R12C
0.010 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 9139
Gene Symbol: CBFA2T2
CBFA2T2
0.010 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 5296
Gene Symbol: PIK3R2
PIK3R2
0.010 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 23368
Gene Symbol: PPP1R13B
PPP1R13B
0.010 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 8874
Gene Symbol: ARHGEF7
ARHGEF7
0.010 Biomarker disease BEFREE In addition, adenocarcinoma showed significantly higher incidence of concomitant expression of Ha-ras p21 and fes P85 as compared with other histologic types of lung cancer. 1310887 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Three of 23 mutations were nonsense mutations; to date, nonsense mutations of p53 have not been reported in lung cancer. 1312896 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Strikingly, a variety of lung cancer derived p53 mutations occurring outside this domain disrupt this activity. 1314165 1992
Entrez Id: 8190
Gene Symbol: MIA
MIA
0.030 Biomarker disease BEFREE We used MIA-15-5 to stain tissue sections from 149 patients with primary lung cancer whose clinico-pathological histories were well documented. 1317941 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE None of these lung cancer patient sera had measurable amounts of p53 antigen. 1322237 1992
Entrez Id: 6303
Gene Symbol: SAT1
SAT1
0.030 AlteredExpression disease BEFREE These results have significance both for the potential use of polyamine analogues in treating specific forms of human lung cancer and for understanding the regulation of SSAT at the molecular level. 1327507 1992
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 Biomarker disease BEFREE While CEA protein concentrations in lung cell lines were similar to those present in G1 cell lines, the ratio of NCA:CEA RNA was significantly higher in lung cancer lines than in colorectal lines. 1330929 1992
Entrez Id: 56994
Gene Symbol: CHPT1
CHPT1
0.070 Biomarker disease BEFREE The CPT-11 resistant human lung cancer cell line, PC-7/CPT, showed 10-fold resistance compared to parental cell line, PC-7. 1332703 1992
Entrez Id: 79947
Gene Symbol: DHDDS
DHDDS
0.070 Biomarker disease BEFREE The CPT-11 resistant human lung cancer cell line, PC-7/CPT, showed 10-fold resistance compared to parental cell line, PC-7. 1332703 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE None of the mutations were G:C to T:A transversions in the coding strand of the p53 gene, which are the most frequent base substitutions associated with tobacco smoking, and none were found at the hotspot codons described in lung cancer. 1347094 1992
Entrez Id: 324
Gene Symbol: APC
APC
0.100 Biomarker disease BEFREE We conclude that loss of heterozygosity occurs frequently for MCC and APC in lung cancer of all histological types and is very frequent in SCLC. 1348017 1992
Entrez Id: 4163
Gene Symbol: MCC
MCC
0.050 Biomarker disease BEFREE We conclude that loss of heterozygosity occurs frequently for MCC and APC in lung cancer of all histological types and is very frequent in SCLC. 1348017 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE Mutations in the P53 tumour suppressor gene in primary lung cancer in Japan. 1348931 1992
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 AlteredExpression disease BEFREE Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. 1350198 1992
Entrez Id: 8661
Gene Symbol: EIF3A
EIF3A
0.050 AlteredExpression disease BEFREE Since geographical and cultural factors may contribute to the development of certain types of cancer, we examined p185 examined p185 expression in 120 tumors from Chinese patients with lung cancers of different cell types and used immunohistochemical staining to determine the extent and general significance of p185 expression in human primary lung cancer. 1350198 1992